1 – 5 of 9
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
(
- Contribution to journal › Article
- 2016
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
(
- Contribution to journal › Article
- 2013
-
Mark
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
(
- Contribution to journal › Article
- 2010
-
Mark
Two-Year Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial.
(
- Contribution to journal › Article
-
Mark
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study
(
- Contribution to journal › Article